GlassScriptPhysician profile
Sakeer Hussain
NPI 1952423071
$73,651.70
in general payments reported to CMS, 2019-2025
80 companies · $15K in 2025
The $15K reported for 2025 was more than what 91% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,889 · 2020: $1,506 · 2021: $11K · 2022: $12K · 2023: $7,455 · 2024: $19K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $22K · Food and Beverage: $8,096 · Honoraria: $7,416 · Travel and Lodging: $2,474 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000 · Education: $307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $21,795.75 |
| Food and Beverage | $8,096.02 |
| Honoraria | $7,415.75 |
| Travel and Lodging | $2,473.63 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
| Education | $306.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $10,662.92 | 2019-2025 | Calquence, Enhertu, Tagrisso |
| Genzyme Corporation | $8,521.99 | 2019-2025 | |
| Seagen INC. | $8,180.77 | 2019-2024 | Tukysa, Padcev, Adcetris |
| Pharmacosmos Therapeutics INC. | $7,831.09 | 2023-2024 | Monoferric, Cosela |
| Incyte Corporation | $6,309.17 | 2019-2025 | Zynyz, Jakafi, Niktimvo |
| Karyopharm Therapeutics INC. | $6,233.18 | 2021-2025 | Xpovio |
| Daiichi Sankyo INC. | $5,535.80 | 2019-2025 | Enhertu, Injectafer, Datroway |
| Regeneron Healthcare Solutions, INC. | $2,384.63 | 2022-2025 | Libtayo |
| Celgene Corporation | $1,847.13 | 2019-2025 | Reblozyl, Pomalyst, Pomalyst |
| Janssen Biotech, INC. | $1,606.36 | 2019-2025 | Rybrevant, Tecvayli, Darzalex |
| Epizyme, INC. | $1,261.50 | 2021 | |
| Rigel Pharmaceuticals, INC. | $1,059.29 | 2019-2023 | Tavalisse, Rezlidhia |
| Avyxa Pharma, LLC | $1,000.00 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $935.89 | 2019-2025 | Opdivo, Opdualag |
| Adaptive Biotechnologies Corporation | $915.33 | 2020-2025 | Clonoseq |
Show all 80 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $909.42 | 2020-2025 | |
| Pfizer INC. | $875.94 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $790.04 | 2019-2025 | Keytruda, Welireg, Lynparza |
| Geron Corporation | $780.00 | 2025 | Rytelo |
| Pharmacyclics LLC, An Abbvie Company | $530.00 | 2019-2023 | Imbruvica, Epkinly |
| Genentech USA, INC. | $447.33 | 2019-2025 | Tecentriq, Polivy, Lunsumio |
| Astellas Pharma US INC | $303.89 | 2019-2025 | Xospata, Padcev, Vyloy |
| Abbvie INC. | $295.66 | 2022-2025 | |
| Lilly USA, LLC | $266.35 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Servier Pharmaceuticals LLC | $239.69 | 2022-2025 | |
| Amgen INC. | $231.01 | 2019-2023 | Lumakras, Xgeva, Nplate |
| Eisai INC. | $218.83 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $194.42 | 2019-2025 | Fruzaqla, Adynovate, Alunbrig |
| Exelixis INC. | $187.34 | 2019-2025 | Cabometyx |
| Array Biopharma INC | $185.70 | 2019-2025 | Mektovi, Braftovi, Lorbrena |
| Boehringer Ingelheim Pharmaceuticals, INC. | $157.97 | 2019-2025 | Gilotrif |
| Ipsen Biopharmaceuticals, INC | $156.61 | 2019-2025 | Onivyde, Tazverik, Somatuline Depot |
| Gilead Sciences, INC. | $130.94 | 2021-2025 | Trodelvy |
| Caris Mpi, INC. | $124.11 | 2025 | Mi Cancer Seek |
| Bayer Healthcare Pharmaceuticals INC. | $116.77 | 2019-2025 | |
| Tersera Therapeutics LLC | $116.62 | 2022-2024 | Quzyttir, Xermelo, Zoladex |
| Aveo Pharmaceuticals, INC. | $111.47 | 2022-2025 | Fotivda |
| Myriad Genetic Laboratories, INC. | $108.69 | 2021-2025 | Precisetumor, Myrisk |
| Jazz Pharmaceuticals INC. | $106.46 | 2020-2024 | Zepzelca |
| Alexion Pharmaceuticals, INC. | $103.43 | 2023-2025 | Ultomiris |
| Comsort, INC | $100.00 | 2019 | |
| Octapharma USA, INC. | $95.47 | 2023-2024 | Octagam Immune Globulin (Human) |
| Genmab U.S., INC. | $88.03 | 2023-2024 | Epkinly |
| Sanofi-Aventis U.S. LLC | $81.99 | 2022 | |
| Stemline Therapeutics INC. | $78.69 | 2024-2025 | Orserdu, Elzonris |
| Blueprint Medicines Corporation | $77.83 | 2020-2023 | Ayvakit |
| Emd Serono, INC. | $77.70 | 2019-2025 | Tepmetko |
| Taiho Oncology, INC. | $77.15 | 2023-2025 | |
| Glaxosmithkline, LLC. | $76.61 | 2021-2025 | Shingrix, Zejula, Jemperli |
| Beone Medicines USA, INC. | $68.82 | 2025 | Tevimbra, Brukinsa |
| Mirati Therapeutics, INC. | $59.37 | 2023-2024 | Krazati |
| Sobi, INC | $59.32 | 2023-2024 | |
| Kyowa Kirin, INC. | $50.42 | 2020-2023 | Poteligeo |
| G1 Therapeutics, INC. | $48.53 | 2022-2023 | Cosela |
| Immunogen, INC. | $44.30 | 2023 | Elahere |
| Acrotech Biopharma INC. | $40.46 | 2023-2025 | Beleodaq |
| Puma Biotechnology, INC. | $39.02 | 2022-2023 | |
| Novocure INC. | $37.00 | 2023-2025 | Optune, Optune Lua (Novottf-200t) |
| Agios Pharmaceuticals, INC. | $34.54 | 2019-2025 | Pyrukynd |
| Pharmaessentia USA Corporation | $33.62 | 2022 | |
| Dendreon Pharmaceuticals LLC | $30.95 | 2019-2025 | Provenge |
| Cti Biopharma Corp. | $29.60 | 2022-2023 | Vonjo |
| Dova Pharmaceuticals | $29.49 | 2019-2020 | |
| Morphosys, US INC. | $28.99 | 2021 | |
| Clovis Oncology, INC. | $27.94 | 2019 | |
| Alnylam Pharmaceuticals INC. | $23.70 | 2023 | Givlaari |
| Beigene USA, INC. | $23.32 | 2024 | Brukinsa |
| Medtronic, INC. | $20.44 | 2024 | Intellis Adaptivestim |
| Janssen Pharmaceuticals, INC | $20.08 | 2023 | Xarelto |
| Accord Healthcare, INC. | $19.37 | 2024 | |
| Deciphera Pharmaceuticals INC. | $19.19 | 2023 | Qinlock |
| Aadi Bioscience, INC. | $18.27 | 2023 | Fyarro |
| Kite Pharma, INC. | $17.32 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $16.85 | 2021 | |
| Coherus Oncology, INC. | $16.01 | 2024 | |
| Sun Pharmaceutical Industries INC. | $16.00 | 2024 | |
| Organon LLC | $14.28 | 2023 | |
| Tempus Ai, INC | $13.31 | 2024 | Xt Cdx |
| Foundation Medicine, INC. | $13.17 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $10.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sakeer Hussain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.